Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Xuanpeng Wu"'
Autor:
Tao Jiang, Hao Wang, Fei Xue, Xuanpeng Wu, Ming Ni, Yuanyuan Wang, Nanzheng Chen, Yong Zhang, Guangjian Zhang, Junke Fu, Xi Liu, Qifei Wu
Publikováno v:
Thoracic Cancer, Vol 14, Iss 32, Pp 3240-3244 (2023)
Abstract Pulmonary polymorphic carcinoma (PPC) is a rare and poorly differentiated form of non‐small cell lung cancer (NSCLC), accounting for just approximately 0.1% to 0.4% of all NSCLC cases. Historically, the conventional treatments for PPC have
Externí odkaz:
https://doaj.org/article/23c51b0e4b6f41bbb2cfebb8c38f7e37
Autor:
Xuanpeng Wu, Hao Wang, Fei Xue, Tao Jiang, Nanzheng Chen, Tianju Wang, Yong Zhang, Guangjian Zhang, Junke Fu, Qifei Wu
Publikováno v:
Thoracic Cancer, Vol 14, Iss 20, Pp 1932-1940 (2023)
Abstract Background The aim of the study was to investigate differences in HLA‐I alleles between lung adenocarcinoma patients and healthy controls and determine their association with PD‐L1 expression and tumor mutational burden (TMB) to understa
Externí odkaz:
https://doaj.org/article/4513592883754e8ea477a36b9ed81d22
Autor:
Xuanpeng Wu, Hao Wang, Fei Xue, Tao Jiang, Nanzheng Chen, Tianju Wang, Yong Zhang, Guangjian Zhang, Junke Fu, Qifei Wu
Publikováno v:
Thoracic Cancer.
Lung cancer remains the leading cause of cancer-related mortality worldwide, adenocarcinoma stands out as the most prevalent and lethal form. Tumour metabolism plays an important role in malignancy progression. The current stage-based approach falls
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f8110c5235c70bfa1182f9f5a62b18d3
https://doi.org/10.21203/rs.3.rs-2728545/v1
https://doi.org/10.21203/rs.3.rs-2728545/v1